Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD

11.54  +0.1 (+0.87%)

After market: 11.54 0 (0%)

Fundamental Rating

4

XHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. XHR may be in some trouble as it scores bad on both profitability and health. XHR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
In the past year XHR had a positive cash flow from operations.
In multiple years XHR reported negative net income over the last 5 years.
XHR had a positive operating cash flow in 4 of the past 5 years.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.56%, XHR is in line with its industry, outperforming 51.16% of the companies in the same industry.
XHR has a Return On Equity (1.27%) which is comparable to the rest of the industry.
XHR has a Return On Invested Capital of 2.49%. This is comparable to the rest of the industry: XHR outperforms 43.41% of its industry peers.
XHR had an Average Return On Invested Capital over the past 3 years of 2.74%. This is in line with the industry average of 3.17%.
Industry RankSector Rank
ROA 0.56%
ROE 1.27%
ROIC 2.49%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

XHR has a Profit Margin of 1.52%. This is comparable to the rest of the industry: XHR outperforms 44.19% of its industry peers.
In the last couple of years the Profit Margin of XHR has declined.
Looking at the Operating Margin, with a value of 8.18%, XHR is doing worse than 81.40% of the companies in the same industry.
In the last couple of years the Operating Margin of XHR has declined.
With a Gross Margin value of 54.32%, XHR is not doing good in the industry: 74.42% of the companies in the same industry are doing better.
XHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.18%
PM (TTM) 1.52%
GM 54.32%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XHR is destroying value.
Compared to 1 year ago, XHR has less shares outstanding
Compared to 5 years ago, XHR has less shares outstanding
XHR has a better debt/assets ratio than last year.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that XHR is in the distress zone and has some risk of bankruptcy.
XHR has a Altman-Z score (0.56) which is comparable to the rest of the industry.
XHR has a debt to FCF ratio of 57.61. This is a negative value and a sign of low solvency as XHR would need 57.61 years to pay back of all of its debts.
With a Debt to FCF ratio value of 57.61, XHR perfoms like the industry average, outperforming 58.14% of the companies in the same industry.
XHR has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
XHR's Debt to Equity ratio of 1.07 is in line compared to the rest of the industry. XHR outperforms 52.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 57.61
Altman-Z 0.56
ROIC/WACC0.33
WACC7.6%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.78 indicates that XHR may have some problems paying its short term obligations.
XHR has a Current ratio (0.78) which is in line with its industry peers.
A Quick Ratio of 0.78 indicates that XHR may have some problems paying its short term obligations.
XHR has a Quick ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 205.26% over the past year.
XHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -23.70% yearly.
The Revenue has been growing slightly by 1.33% in the past year.
The Revenue has been decreasing by -1.99% on average over the past years.
EPS 1Y (TTM)205.26%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%537.5%
Revenue 1Y (TTM)1.33%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.02%

3.2 Future

Based on estimates for the next years, XHR will show a very strong growth in Earnings Per Share. The EPS will grow by 42.53% on average per year.
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.17% yearly.
EPS Next Y-30.2%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year2.29%
Revenue Next 2Y2.96%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.90, the valuation of XHR can be described as rather expensive.
Based on the Price/Earnings ratio, XHR is valued a bit cheaper than 74.42% of the companies in the same industry.
XHR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.10.
Based on the Price/Forward Earnings ratio of 51.54, the valuation of XHR can be described as expensive.
XHR's Price/Forward Earnings ratio is in line with the industry average.
XHR is valuated expensively when we compare the Price/Forward Earnings ratio to 20.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.9
Fwd PE 51.54
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than the industry average as 72.09% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as XHR.
Industry RankSector Rank
P/FCF 50.53
EV/EBITDA 11.31
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

XHR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.17%
EPS Next 3Y42.53%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.37%, XHR is a good candidate for dividend investing.
In the last 3 months the price of XHR has falen by -22.81%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 6.64, XHR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.43, XHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.37%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of XHR decreased recently.
Dividend Growth(5Y)-15.89%
Div Incr Years1
Div Non Decr Years1
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 304.02% of its income as dividend. This is not a sustainable payout ratio.
DP304.02%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (5/5/2025, 8:04:00 PM)

After market: 11.54 0 (0%)

11.54

+0.1 (+0.87%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners96.16%
Inst Owner Change-0.31%
Ins Owners0.91%
Ins Owner Change0.04%
Market Cap1.17B
Analysts74.55
Price Target12.75 (10.49%)
Short Float %2.64%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 4.37%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP304.02%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-31 2025-03-31 (0.14)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-94.95%
Min EPS beat(2)-199.01%
Max EPS beat(2)9.11%
EPS beat(4)3
Avg EPS beat(4)3.89%
Min EPS beat(4)-199.01%
Max EPS beat(4)164.03%
EPS beat(8)4
Avg EPS beat(8)36.05%
EPS beat(12)7
Avg EPS beat(12)98.23%
EPS beat(16)9
Avg EPS beat(16)73.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.78%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.76%
Min Revenue beat(4)-1.98%
Max Revenue beat(4)2.48%
Revenue beat(8)2
Avg Revenue beat(8)-0.68%
Revenue beat(12)5
Avg Revenue beat(12)0.78%
Revenue beat(16)9
Avg Revenue beat(16)2.2%
PT rev (1m)-21.05%
PT rev (3m)-28.98%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-56.67%
EPS NY rev (1m)4.19%
EPS NY rev (3m)-64.56%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-2.73%
Revenue NY rev (1m)-2.01%
Revenue NY rev (3m)-2.54%
Valuation
Industry RankSector Rank
PE 19.9
Fwd PE 51.54
P/S 1.13
P/FCF 50.53
P/OCF 7.15
P/B 0.94
P/tB 0.95
EV/EBITDA 11.31
EPS(TTM)0.58
EY5.03%
EPS(NY)0.22
Fwd EY1.94%
FCF(TTM)0.23
FCFY1.98%
OCF(TTM)1.61
OCFY13.99%
SpS10.24
BVpS12.25
TBVpS12.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 1.27%
ROCE 3.15%
ROIC 2.49%
ROICexc 2.56%
ROICexgc 2.61%
OM 8.18%
PM (TTM) 1.52%
GM 54.32%
FCFM 2.23%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 57.61
Debt/EBITDA 6.24
Cap/Depr 109.17%
Cap/Sales 13.53%
Interest Coverage 0.98
Cash Conversion 76.59%
Profit Quality 146.97%
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 0.56
F-Score6
WACC7.6%
ROIC/WACC0.33
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)205.26%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%537.5%
EPS Next Y-30.2%
EPS Next 2Y22.17%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)1.33%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%8.02%
Revenue Next Year2.29%
Revenue Next 2Y2.96%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y-12.68%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year198.42%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-69.98%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y-17.34%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%